tradingkey.logo

QuidelOrtho Corp

QDEL
29.100USD
+0.410+1.43%
收盘 02/06, 16:00美东报价延迟15分钟
1.98B总市值
亏损市盈率 TTM

QuidelOrtho Corp

29.100
+0.410+1.43%

关于 QuidelOrtho Corp 公司

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp简介

公司代码QDEL
公司名称QuidelOrtho Corp
上市日期Feb 01, 1991
CEOBlaser (Brian J)
员工数量6600
证券类型Ordinary Share
年结日Feb 01
公司地址9975 Summers Ridge Road
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92121
电话18585521100
网址https://www.quidelortho.com/
公司代码QDEL
上市日期Feb 01, 1991
CEOBlaser (Brian J)

QuidelOrtho Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.02K
+750.00%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
2.52K
+2523.00%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%
地区USD
名称
营收
占比
North America
381.40M
54.49%
Other
142.10M
20.30%
EMEA
91.80M
13.12%
China
84.60M
12.09%
业务
地区
业务USD
名称
营收
占比
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
其他
45.61%
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
其他
45.61%
股东类型
持股股东
占比
Investment Advisor
68.40%
Investment Advisor/Hedge Fund
35.50%
Hedge Fund
14.78%
Research Firm
2.25%
Pension Fund
1.00%
Individual Investor
1.00%
Private Equity
0.71%
Bank and Trust
0.55%
Sovereign Wealth Fund
0.52%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
658
84.07M
123.75%
-20.23M
2025Q3
656
79.44M
116.95%
-23.17M
2025Q2
684
78.51M
115.63%
-21.42M
2025Q1
726
76.59M
113.26%
-21.60M
2024Q4
747
75.07M
111.30%
-13.02M
2024Q3
744
73.58M
109.44%
-4.02M
2024Q2
767
70.18M
104.79%
-7.57M
2024Q1
799
67.05M
100.24%
-5.28M
2023Q4
828
68.21M
102.09%
-2.95M
2023Q3
842
70.19M
105.17%
-4.01M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Investment Management, Inc.
11.01M
16.21%
-124.03K
-1.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.32M
13.72%
+39.16K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
7.60M
11.19%
-165.71K
-2.13%
Sep 30, 2025
Rubric Capital Management LP
4.64M
6.83%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.44M
6.54%
+1.89M
+73.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.86M
4.21%
+350.64K
+13.98%
Sep 30, 2025
Newtyn Management, LLC
2.70M
3.97%
+994.33K
+58.30%
Sep 30, 2025
State Street Investment Management (US)
2.67M
3.93%
-32.20K
-1.19%
Sep 30, 2025
Invesco Advisers, Inc.
2.66M
3.92%
+1.33M
+100.02%
Sep 30, 2025
American Century Investment Management, Inc.
2.12M
3.11%
+199.91K
+10.44%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.75%
Invesco S&P SmallCap Health Care ETF
1.12%
Ballast Small/Mid Cap ETF
0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.56%
JPMorgan Fundamental Data Science Small Core ETF
0.35%
State Street SPDR S&P 600 Small Cap Value ETF
0.26%
Avantis US Small Cap Value ETF
0.26%
iShares S&P Small-Cap 600 Value ETF
0.25%
iShares U.S. Medical Devices ETF
0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
0.19%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.75%
Invesco S&P SmallCap Health Care ETF
占比1.12%
Ballast Small/Mid Cap ETF
占比0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比0.56%
JPMorgan Fundamental Data Science Small Core ETF
占比0.35%
State Street SPDR S&P 600 Small Cap Value ETF
占比0.26%
Avantis US Small Cap Value ETF
占比0.26%
iShares S&P Small-Cap 600 Value ETF
占比0.25%
iShares U.S. Medical Devices ETF
占比0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
占比0.19%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI